

Compact for Safe Cosmetics
|
Animal Testing Policy |


Given the incomplete information made available by companies and the government, EWG provides additional information on personal care product ingredients from the published scientific literature. The chart below indicates that research studies have found that exposure to one or more ingredients in this product -- not the product itself -- caused the indicated health effect(s) in the studies reviewed by Skin Deep researchers. Actual health risks, if any, will vary based on the level of exposure to the ingredient and individual susceptibility -- information not available in Skin Deep.
Ingredients in this product are linked to: | |
![]() | Cancer |
![]() | Developmental/reproductive toxicity |
![]() | Violations, restrictions & warnings |
![]() | Allergies/immunotoxicity |
![]() | Other concerns for ingredients used in this product: Neurotoxicity, Endocrine disruption, Persistence and bioaccumulation, Organ system toxicity (non-reproductive), Miscellaneous, Multiple, additive exposure sources, Irritation (skin, eyes, or lungs), Enhanced skin absorption, Contamination concerns, Occupational hazards, Biochemical or cellular level changes |
Ingredients from packaging: INGREDIENTS: #1: WATER (AQUA), CAPRYLIC/CAPRIC TRIGLYCERIDE, PROPYLENE GLYCOL, CYCLOMETHICONE, ETHYLHEXYL METHOXYCINNAMATE, POTASSIUM CETYL PHOSPHATE, OCTYLDODECANOL, GLYCERIN, PROPYLENE GLYCOL STEARATE, SILICA SQUALANE, GLYCERYL STEARATE, CETEARYL ALCOHOL, BENZOPHENONE 3, HYDROGENATED LECITHIN, BIS-PEG-18 METHYL ETHER DIMETHYL SILANE, CHOLETH-24, CETETH-24, PEG-100 STEARATE, ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER, METHYLPARABEN, SORBIC ACID, SODIUM DEHYDROACETATE, PHENOXYETHANOL, PROPYLPARABEN, TETRASODIUM EDTA, FRAGRANCE (PARFUM), CAMELLIA KISSI SEED OIL, SODIUM HYALURONATE, HECTORITE, MINERAL OIL, XANTHAN GUM, PRUNUS ARMENIACA (APRICOT) KERNEL OIL, TOCOPHEROL, BUTYLPARABEN, ETHYLPARABEN, ASCORBYL PALMITATE, ISOBUTYLPARABEN, CRATAEGUS OXYACANTHA EXTRACT, LINALOOL, HEXYL CINNAMAL. +/-[MAY CONTAIN]: MICA (CI 77019), TITANIUM DIOXIDE (CI 77891), IRON OXIDES (CI 77491, CI 77492, CI 77499), ULTRAMARINES (CI 77007).
| score | data gap | concerns | |
| METHYLPARABEN | 10 | 63% | Violations, restrictions & warnings, Endocrine disruption, Allergies/immunotoxicity, Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs), Biochemical or cellular level changes |
| OXYBENZONE (BENZOPHENONE-3) (Active Ingredient) | 9 | 55% | Developmental/reproductive toxicity, Violations, restrictions & warnings, Endocrine disruption, Allergies/immunotoxicity, Persistence and bioaccumulation, Enhanced skin absorption, Biochemical or cellular level changes |
| FRAGRANCE | 8 | 100% | Neurotoxicity, Allergies/immunotoxicity, Miscellaneous |
| OCTINOXATE (OCTYL METHOXYCINNAMATE) ETHYLHEXYL METHOXYCINNAMATE (Active Ingredient) | 8 | 65% | Violations, restrictions & warnings, Endocrine disruption, Allergies/immunotoxicity, Persistence and bioaccumulation, Enhanced skin absorption, Biochemical or cellular level changes |
| SILICA | 1 | 69% | Biochemical or cellular level changes |
| PEG-100 STEARATE | 4 | 69% | Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs), Contamination concerns (ETHYLENE OXIDE, 1,4-DIOXANE, ETHYLENE OXIDE, 1,4-DIOXANE) |
| BUTYLPARABEN | 6 | 79% | Developmental/reproductive toxicity, Endocrine disruption, Allergies/immunotoxicity, Organ system toxicity (non-reproductive), Biochemical or cellular level changes |
| BIS-PEG-18 METHYL ETHER DIMETHYL SILANE | 4 | 76% | Organ system toxicity (non-reproductive), Contamination concerns (ETHYLENE OXIDE, 1,4-DIOXANE) |
| ETHYLPARABEN | 5 | 80% | Endocrine disruption, Allergies/immunotoxicity, Organ system toxicity (non-reproductive) |
| PROPYLPARABEN | 5 | 71% | Developmental/reproductive toxicity, Endocrine disruption, Allergies/immunotoxicity, Organ system toxicity (non-reproductive) |
| LINALOOL | 5 | 65% | Violations, restrictions & warnings, Allergies/immunotoxicity, Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs) |
| CETETH-24 | 3 | 84% | Contamination concerns (ETHYLENE OXIDE, 1,4-DIOXANE, ETHYLENE OXIDE, 1,4-DIOXANE) |
| TITANIUM DIOXIDE (NON-NANO) | 1 | 81% | Allergies/immunotoxicity, Organ system toxicity (non-reproductive), Occupational hazards, Biochemical or cellular level changes |
| MINERAL OIL | 2 | 73% | Organ system toxicity (non-reproductive), Occupational hazards |
| PHENOXYETHANOL | 4 | 67% | Violations, restrictions & warnings, Allergies/immunotoxicity, Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs), Occupational hazards |
| HEXYL CINNAMAL | 4 | 65% | Violations, restrictions & warnings, Allergies/immunotoxicity, Irritation (skin, eyes, or lungs) |
| PROPYLENE GLYCOL | 4 | 60% | Allergies/immunotoxicity, Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs), Enhanced skin absorption |
| CHOLETH-24 | 3 | 92% | Irritation (skin, eyes, or lungs), Contamination concerns (ETHYLENE OXIDE, 1,4-DIOXANE, ETHYLENE OXIDE, 1,4-DIOXANE) |
| ISOBUTYLPARABEN | 3 | 83% | Allergies/immunotoxicity, Organ system toxicity (non-reproductive) |
| SORBIC ACID | 3 | 80% | Allergies/immunotoxicity, Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs) |
| CI 77491 | 2 | 76% | Persistence and bioaccumulation, Occupational hazards, Biochemical or cellular level changes |
| MICA | 3 | 75% | Persistence and bioaccumulation, Organ system toxicity (non-reproductive), Occupational hazards |
| CI 77499 | 3 | 74% | Persistence and bioaccumulation, Organ system toxicity (non-reproductive), Occupational hazards, Biochemical or cellular level changes |
| ULTRAMARINES | 2 | 90% | Multiple, additive exposure sources |
| TOCOPHEROL | 2 | 87% | Contamination concerns (HYDROQUINONE) |
| IRON OXIDES | 2 | 85% | Persistence and bioaccumulation, Enhanced skin absorption |
| CYCLOMETHICONE | 2 | 83% | Persistence and bioaccumulation, Organ system toxicity (non-reproductive) |
| TETRASODIUM EDTA | 2 | 81% | Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs), Enhanced skin absorption, Occupational hazards |
| SODIUM DEHYDROACETATE | 2 | 78% | Occupational hazards |
| HECTORITE | 2 | 75% | Violations, restrictions & warnings |
| GLYCERIN | 2 | 74% | Organ system toxicity (non-reproductive), Occupational hazards |
| HYDROGENATED LECITHIN | 2 | 74% | Enhanced skin absorption, Contamination concerns (NITROSAMINES) |
| CAPRYLIC/ CAPRIC TRIGLYCERIDE | 0 | 94% | none identified |
| CETEARYL ALCOHOL | 0 | 93% | none identified |
| SQUALANE | 1 | 93% | Irritation (skin, eyes, or lungs) |
| ASCORBYL PALMITATE (VITAMIN C PALMITATE) | 1 | 88% | none identified |
| GLYCERYL MONOSTEARATE GLYCERYL STEARATE | 1 | 88% | none identified |
| PROPYLENE GLYCOL STEARATE | 1 | 88% | none identified |
| OCTYLDODECANOL | 1 | 87% | Irritation (skin, eyes, or lungs) |
| SODIUM HYALURONATE | 1 | 83% | none identified |
| ACRYLATES/ C10-30 ALKYL ACRYLATE CROSSPOLYMER | 0 | 100% | none identified |
| CAMELLIA KISSI SEED OIL | 0 | 100% | none identified |
| POTASSIUM CETYL PHOSPHATE | 0 | 100% | none identified |
| CI 77492 | 0 | 100% | none identified |
| CRATAEGUS OXYACANTHA EXTRACT | 0 | 100% | none identified |
| PRUNUS ARMENIACA (APRICOT) KERNEL OIL | 0 | 94% | none identified |
| XANTHAN GUM | 0 | 94% | none identified |
| WATER | 0 | 0% | innocuous |
*This table includes all possible cancer concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show tumor formation at high doses | MINERAL OIL | |
| One or more in vitro tests non-mammalian cells show positive mutation results | PHENOXYETHANOL, OXYBENZONE (BENZOPHENONE-3), LINALOOL | |
| One or more animal studies show tumor formation at moderate doses | PEG-100 STEARATE | |
| One or more in vitro tests on mammalian cells show positive mutation results | TOCOPHEROL, TITANIUM DIOXIDE (NON-NANO), SORBIC ACID, SODIUM DEHYDROACETATE, PROPYLPARABEN, PROPYLENE GLYCOL, METHYLPARABEN, GLYCERIN, ETHYLPARABEN, BUTYLPARABEN | |
| Cancer - not classifiable/not likely to be human carcinogen | CI 77499, CI 77491 |
*This table includes all possible developmental/reproductive toxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show reproductive effects at high doses | PEG-100 STEARATE, SODIUM DEHYDROACETATE | |
| One or more animal studies show reproductive effects at moderate doses | SODIUM HYALURONATE, | |
| One or more animal studies show reproductive effects at moderate doses | OCTINOXATE (OCTYL METHOXYCINNAMATE) | |
| One or more animal studies show reproductive effects at high doses | ETHYLPARABEN | |
| One or more animal studies show reproductive effects at moderate doses | PROPYLENE GLYCOL, GLYCERIN | |
| Limited evidence of developmental toxicity | OXYBENZONE (BENZOPHENONE-3) | |
| One or more animal studies show any effects at low doses | PROPYLPARABEN | |
| One or more animal studies show any effects at very low doses | BUTYLPARABEN |
*This table includes all possible violations, restrictions & warnings concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Determined safe for use in cosmetics, subject to concentration or use limitations - Safe for use in cosmetics with some qualifications | PEG-100 STEARATE, BIS-PEG-18 METHYL ETHER DIMETHYL SILANE, PROPYLENE GLYCOL | |
| Recommended restricted in cosmetics - use, concentration, or manufacturing restrictions - Product type restrictions or differences noted in safety assessment by industry panel | HECTORITE | |
| Determined safe for use in cosmetics, subject to concentration or use limitations - Safe for use in cosmetics with some qualifications | HYDROGENATED LECITHIN | |
| Recommended restricted in cosmetics - use, concentration, or manufacturing restrictions - Fragrance subject to restrictions: safe only within recommended use or concentration limitsn) | HEXYL CINNAMAL, LINALOOL | |
| Restricted in cosmetics (recommendations or requirements) - use, concentration, or manufacturing restrictions - Japan - restricted for use in some types of cosmetics (concentration limit) | products for use around the eyes; products for use on the lips | OCTINOXATE (OCTYL METHOXYCINNAMATE) |
| Violation of government restrictions - Banned or found unsafe for use in cosmetics | METHYLPARABEN | |
| Restricted in cosmetics (recommendations or requirements) - use, concentration, or manufacturing restrictions - Japan - restricted for use in some types of cosmetics (concentration limit) | OXYBENZONE (BENZOPHENONE-3), PHENOXYETHANOL |
*This table includes all possible neurotoxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show brain and nervous system effects at high doses | CETETH-24, ULTRAMARINES, SODIUM DEHYDROACETATE, PROPYLENE GLYCOL, OXYBENZONE (BENZOPHENONE-3), HEXYL CINNAMAL, GLYCERIN | |
| One or more animal studies show brain and nervous system effects at moderate doses | SODIUM HYALURONATE, PHENOXYETHANOL, METHYLPARABEN, LINALOOL | |
| Moderate evidence of human neurotoxicity | FRAGRANCE |
*This table includes all possible endocrine disruption concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show endocrine system disruption at high doses | GLYCERIN | |
| One or more animal studies show endocrine disruption at moderate doses | ISOBUTYLPARABEN | |
| Human any disruptor - moderate evidence | OXYBENZONE (BENZOPHENONE-3) | |
| Human any disruptor - strong evidence | PROPYLPARABEN, OCTINOXATE (OCTYL METHOXYCINNAMATE), METHYLPARABEN, ETHYLPARABEN, BUTYLPARABEN |
*This table includes all possible allergies/immunotoxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show gastrointestinal effects at moderate doses | MICA | |
| Limited evidence of skin and immune system toxicity | PHENOXYETHANOL | |
| Human skin toxicant - strong evidence | SORBIC ACID | |
| Limited evidence of skin and immune system toxicity | PROPYLENE GLYCOL | |
| One or more human case studies show possible photoallergic effects | OCTINOXATE (OCTYL METHOXYCINNAMATE) | |
| One or more animal studies show immune effects at low doses | TITANIUM DIOXIDE (NON-NANO) | |
| Human skin toxicant - strong evidence | PROPYLPARABEN, METHYLPARABEN, ISOBUTYLPARABEN, ETHYLPARABEN, BUTYLPARABEN | |
| Possible human photoallergenic toxicant | OXYBENZONE (BENZOPHENONE-3), LINALOOL, HEXYL CINNAMAL | |
| Known human immune system toxicant | FRAGRANCE |
*This table includes all possible persistence and bioaccumulation concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Not suspected to be bioaccumulative | TITANIUM DIOXIDE (NON-NANO) | |
| Ingredient is suspected or measured to accumulate in people | OXYBENZONE (BENZOPHENONE-3), OCTINOXATE (OCTYL METHOXYCINNAMATE) | |
| Persistent, bioaccumulative in wildlife | CYCLOMETHICONE | |
| Persistent, bioaccumulative in wildlife and humans | CI 77499, IRON OXIDES, MICA |
*This table includes all possible organ system toxicity (non-reproductive) concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show broad systemic effects at high doses (low dose studies may be unavailable for this ingredient) | ASCORBYL PALMITATE (VITAMIN C PALMITATE), HEXYL CINNAMAL, CETETH-24, ULTRAMARINES, | |
| One or more animal studies show liver effects at high doses (low dose studies may be unavailable for this ingredient) | OCTINOXATE (OCTYL METHOXYCINNAMATE) | |
| Limited evidence of sense organ toxicity | PEG-100 STEARATE | |
| One or more animal studies show broad systemic effects at moderate doses (low dose studies may be unavailable for this ingredient) | GLYCERYL MONOSTEARATE, PROPYLENE GLYCOL STEARATE | |
| Limited evidence of sense organ toxicity | BIS-PEG-18 METHYL ETHER DIMETHYL SILANE, SORBIC ACID, PROPYLPARABEN, ISOBUTYLPARABEN, ETHYLPARABEN, BUTYLPARABEN, CI 77499 | |
| One or more animal studies show sense organ effects at low doses | products for use around the eyes, mouth, or lips | MINERAL OIL |
| One or more animal studies show sense organ effects at very low doses | products for use around the eyes, mouth, or lips | PHENOXYETHANOL |
| One or more animal studies show sense organ effects at low doses | products for use around the eyes, mouth, or lips | LINALOOL |
| Limited evidence of eye toxicity | products for use around the eyes | TETRASODIUM EDTA |
| Possible human respiratory toxicant | MICA | |
| One or more animal studies show cardiovascular effects at very low doses | TITANIUM DIOXIDE (NON-NANO), GLYCERIN | |
| Known human any toxicant | METHYLPARABEN | |
| One or more animal studies show broad systemic effects at moderate doses (low dose studies may be unavailable for this ingredient) | SODIUM DEHYDROACETATE, | |
| One or more animal studies show cardiovascular effects at moderate doses (low dose studies may be unavailable for this ingredient) | OXYBENZONE (BENZOPHENONE-3) | |
| One or more animal studies show sense organ effects at moderate doses (low dose studies may be unavailable for this ingredient) | products for use around the eyes, mouth, or lips | CYCLOMETHICONE, OCTYLDODECANOL, PROPYLENE GLYCOL, SILICA, SODIUM HYALURONATE |
*This table includes all possible miscellaneous concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Ingredient not fully labeled - identity unknown | FRAGRANCE |
*This table includes all possible multiple, additive exposure sources concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Designated as safe for general or specific, limited use in food | CI 77491, CI 77499, PEG-100 STEARATE, BIS-PEG-18 METHYL ETHER DIMETHYL SILANE, XANTHAN GUM, TOCOPHEROL, TITANIUM DIOXIDE (NON-NANO), TETRASODIUM EDTA, IRON OXIDES, SORBIC ACID, PROPYLENE GLYCOL, PROPYLENE GLYCOL STEARATE, SODIUM DEHYDROACETATE, PRUNUS ARMENIACA (APRICOT) KERNEL OIL, PROPYLPARABEN, MINERAL OIL, METHYLPARABEN, BUTYLPARABEN, LINALOOL, GLYCERYL MONOSTEARATE, GLYCERIN, ASCORBYL PALMITATE (VITAMIN C PALMITATE) | |
| Used in food or as an additive with limited or no toxicity information available | ULTRAMARINES | |
| Designated as safe for general or specific, limited use in food | HEXYL CINNAMAL |
*This table includes all possible ecotoxicology concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Suspected to be an environmental toxin | CYCLOMETHICONE | |
| Not suspected to be an environmental toxin | TITANIUM DIOXIDE (NON-NANO) | |
| Wildlife and environmental toxicity | OXYBENZONE (BENZOPHENONE-3), OCTINOXATE (OCTYL METHOXYCINNAMATE) | |
| Wildlife and environmental toxicity | PROPYLPARABEN |
*This table includes all possible irritation (skin, eyes, or lungs) concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Not likely to be a skin irritant in humans | OXYBENZONE (BENZOPHENONE-3) | |
| One or more animal studies show skin irritation at high doses | CETETH-24 | |
| One or more animal studies show skin irritation at moderate doses | TITANIUM DIOXIDE (NON-NANO), SODIUM HYALURONATE, MINERAL OIL, GLYCERIN, CYCLOMETHICONE, BUTYLPARABEN | |
| One or more animal studies show skin irritation at low doses | TETRASODIUM EDTA, SQUALANE, METHYLPARABEN | |
| One or more animal studies show skin irritation at very low doses | PEG-100 STEARATE, SORBIC ACID, LINALOOL, HEXYL CINNAMAL, CHOLETH-24 | |
| Human any irritant - strong evidence | products for use around the eyes, on the skin, or may be aerosolized (airborne) | OCTYLDODECANOL |
| Classified as skin irritant | PROPYLENE GLYCOL, PHENOXYETHANOL |
*This table includes all possible data gaps concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
*This table includes all possible occupational hazards concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Allowed workplace exposures restricted to moderate doses | CI 77499, MINERAL OIL | |
| Allowed workplace exposures restricted to low doses | TETRASODIUM EDTA | |
| Allowed workplace exposures restricted to low doses | MICA | |
| Allowed workplace exposures restricted to moderate doses | GLYCERIN | |
| Allowed workplace exposures restricted to very low doses | CI 77491 | |
| Allowed workplace exposures restricted to low doses | TITANIUM DIOXIDE (NON-NANO), PHENOXYETHANOL, SODIUM DEHYDROACETATE |
*This table includes all possible biochemical or cellular level changes concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Interferes with gene expresion | METHYLPARABEN, BUTYLPARABEN | |
| Produces excess reactive oxygen species that can interfere with cellular signaling, cause mutations, lead to cell death and may be implicated in cardiovascular disease. | OCTINOXATE (OCTYL METHOXYCINNAMATE), OXYBENZONE (BENZOPHENONE-3) | |
| One or more animal studies show blood sugar changes at high doses where the human health implications are not yet well understood | PROPYLENE GLYCOL | |
| One or more animal studies show biochemical changes at low doses where the human health implications are not yet well understood | CI 77499 | |
| One or more animal studies show biochemical changes at high doses where the human health implications are not yet well understood | CYCLOMETHICONE, GLYCERIN, CETETH-24 | |
| One or more animal studies show biochemical changes at low doses where the human health implications are not yet well understood | CI 77491 | |
| One or more animal studies show biochemical changes at very low doses where the human health implications are not yet well understood | SILICA, TITANIUM DIOXIDE (NON-NANO) |
No items in basket.
Add this product
Looking for a product report that we don't have in Skin Deep? Sign up to enter it into the Skin Deep database and leave product reviews.
We always want Skin Deep to be free to the public, but delivering high-quality research costs time and money. Help by donating just the cost of a bar of soap or bottle of shampoo.
Stay informed with email updates on toxics in everyday products and how they can affect your health.
Find out more about the Campaign for Safe Cosmetics.